Introduction
============

Nephrotoxicity can be defined as renal dysfunction that arises as a direct result if exposure to external agents such as drugs and environmental chemicals. Many therapeutic agents have been shown to induce clinically significant nephrotoxicity.^([@B1])^ Aminoglycoside antibiotics have been widely used for gram-negative infections. However, their nephrotoxicity and their ototoxicity are major limitations in clinical use.^([@B2])^ Gentamicin (GM) is an aminoglycoside antibiotic which is commonly used for the treatment of infections caused by gram-negative bacteria.^([@B3])^ However, complications attributable to aminoglycoside toxicity rank as one of the most common reasons for prolonging hospital stays in the developed world,^([@B4])^ as it has been estimated that up to 30% of patients treated with GM for more than 7 days show some signs of nephrotoxicity.^([@B5])^

Reactive oxygen species (ROS) and reactive nitrogen species (RNS) generated by xenobiotics, such as toxicants and drugs, play crucial role in the initiation, and progression of nephrotoxicity and renal injuries.^([@B6])^ Antioxidant agents can mitigate these deleterious effects in the kidney through modification of the oxidant--antioxidant balances. Numerous recent studies, however, documented that some synthetic antioxidants such as butylated hydroxyl anisole (E320) and butylated hydroxyl toluene (E321) can also induce redox-mediated tissue damages. The toxicities of these compounds include hepatotoxicity, pneumotoxicity, nephrotoxicity, and carcinogenic effects.^([@B7],[@B8])^ More and more attention has therefore recently been paid to natural antioxidant products with lower adverse side effects.

Recently, there has been renewed interest in medicinal plants that have been found to have certain preventive measures in the treatment of diseases. Many plant products are rich in polyphenolics including tannins and flavonoids, which are group of compounds with diverse in chemical structure, characteristics and widely recognized as naturally occurring antioxidants. Reports revealed that compounds in their natural formulations are more active than isolated form.^([@B9])^

The plant *Casuarina equisetifolia* Forst (in Bangladesh known as Jhau gachh, Hari) belongs to the family Casuarinaceae. Extracts of leaves exhibit anticancer properties.^([@B10])^ Bark is astringent and in stomachache, diarrhea, dysentery and nervous disorders.^([@B11])^ Seeds are anthelmintic, antispasmodic and antidiabetic.^([@B12])^

Thus the purpose of the present study is to investigate the nephroprotective effect of methanolic extract of *Casuarina equisetifolia* leaves on GM-induced nephrotoxicity and oxidative stress in rats and also the phytochemical analysis was carried out.

Materials and Methods
=====================

Chemicals
---------

GM sulfate, available commercially as Epigent (80 mg/2 ml ampoules), was provided by the Egyptian International Pharmaceutical Industries Co. (EIPICO, 10th of Ramadan City, Egypt). 2,2-Diphenyl-1-picrylyhydrazyl hydrate (DPPH) was procured from Sigma Aldrich (St. Louis, MO). All other chemicals used throughout this study were of pure analytical grades.

Preparation of the extract
--------------------------

Samples of *Casuarina equisetifolia* were purchased from El-Orman Garden, Ministry of Agriculture, Egypt. The dried leaves of *Casuarina equisetifolia* (2 kg) were finely powdered and exhaustively extracted with 100% methanol, by maceration at room temperature. The crude methanolic extract was evaporated to dryness under reduced pressure. The process of maceration and evaporation was repeated till exhaustion of the plants powder, and then the residues were combined and weighed.

Phytochemical screening of the extracts
---------------------------------------

Preliminary phytochemical screening for alkaloids, steroids, carbohydrates, tannins, fixed oils, proteins, triterpenoids, deoxysugar, flavonoid, cyanogenetic and coumarin glycosides carried out on the extract according to the procedures of Khandelwal.^([@B13])^

Separation and quantification of phenolic compounds
---------------------------------------------------

Was conducted on Agilent Technologies 1200 Series Separations Module (GmbH, Germany) equipped with G1322A Vacuum degasser, G1311A Quaternary Pump, G1314B Variable Wavelength Detector (SL), G1328B Manual Injector and G1316A Thermostatted Column Compartment was used for HPLC analysis.

The extract was separated at 35°C on a reverse phase HPLC, ACE 5 µm C18 column with dimensions 250 × 4.6 mm, detection at 280 nm. The mobile phase used was a gradient of A (CH~3~COOH 2.5%), B (CH~3~COOH 8%) and C (acetonitrile). The best separation was obtained with the following gradient: at 0 min, 5% B; at 20 min, 10% B. The solvent flow rate was 1 m/min. The volume injected was 20 µl. Phenolic compounds were quantified by using standard calibration for each compound and expressed as mg/100 g.

Separation and quantification of flavonoids
-------------------------------------------

This was done using the above mentioned HPLC system and the same column with a mobile phase of methanol: water 1:1 (0--10 min) and 7:3 (10--20 min) at a flow-rate of 1 ml/min and detection at 339 nm. Each identified flavonoid was quantified by using standard calibration for each compound and expressed as mg %.

Determination of flavonoid content
----------------------------------

Total flavonoidal content was determined by a pharmacopeia method (State Pharmacopeia of USSR, using rutin as a reference compound. One ml of plant extract in methanol (10 g/L) was mixed with 1 ml aluminium trichloride in ethanol (20 g/L) and diluted with ethanol to 25 ml. The absorption at 415 nm was read after 40 min at 20°C. Blank samples were prepared from 1 ml plant extract and 1 drop acetic acid, and diluted to 25 ml. The absorption of rutin solutions was measured under the same conditions. Standard rutin solutions were prepared from 0.05 g rutin. All determinations were carried out in duplicate. The amount of flavonoids in plant extracts in rutin equivalents (RE) was calculated by the following formula (Eq. 1):

where: X - flavonoid content, mg/g plant extract in RE; A - the absorption of plant extract solution; A0 - the absorption of standard rutin solution; m - the weight of plant extract, g; m0 - the weight of rutin in the solution, g.

Determination of antioxidant activity of *Casuarina equisetifolia* extract *in vitro*
-------------------------------------------------------------------------------------

### DPPH^•^ radical scavenging assay.

Radical scavenging activity of plant extracts against stable DPPH^•^, was determined spectrophotometrically. When DPPH^•^ reacts with an antioxidant compound, which can donate hydrogen, it is reduced. The changes in colour (from deep-violet to light-yellow) were measured at 520 nm on a UV/visible light spectrophotometer.^([@B14])^

### Nitric oxide (NO) radical inhibition assay.

NO radical inhibition can be estimated by the use of Griess Illosvoy reaction.^([@B15])^ In this assay, Griess Illosvoy reagent was modified by using naphthyl ethylene diamine dihydrochloride (0.1% w/v) instead of 1-napthylamine (5%). The reaction mixture (3 ml) containing sodium nitroprusside (10 mM, 2 ml), phosphate buffer saline (0.5 ml) and extract (100--1,000 µg) was incubated at 25°C for 150 min. After incubation, 0.5 ml of the reaction mixture mixed with 1 ml of sulfanilic acid reagent (0.33% in 20% glacial acetic acid) and allowed to stand for 5 min for completing diazotization. Then, 1 ml of naphthyl ethylene diamine dihydrochloride was added, mixed and allowed to stand for 30 min at 25°C. A pink coloured chromophore is formed in diffused light. The absorbance of these solutions was measured at 540 nm against the corresponding blank solutions.

### Assay of reducing power.

The reductive capability of the extract was quantified by the method of Oyaizu, 1986.^([@B16])^ One ml of Extract (100--1,000 µg) in distilled water was mixed with 2.5 ml of 0.2 M phosphate buffer (pH 6.6) and 2.5 ml of 1% potassium ferricyanide \[K~3~ Fe (CN)~6~\]. The mixture was incubated at 50°C for 20 min. Then, the reaction was terminated by adding 2.5 ml of 10% trichloroacetic acid. The upper layer of solution (2.5 ml) was mixed with distilled water (2.5 ml) and 0.5 ml of 0.1% FeCl~3~. Blank reagent is prepared as above without adding extract. The absorbance was measured at 700 nm in a spectrophotometer against a blank sample. Increased absorbance of the reaction mixture indicated greater reducing power.

### Hydroxyl radical (^•^OH) scavenging assay.

The reaction mixture (3 ml) containing 1 ml FeSO~4~ (1.5 mM), 0.7 ml hydrogen peroxide (6 mM), 0.3 ml sodium salicylate (20 mM) and varying concentrations of the extract (2--10 µg) were taken. After incubation for 1 h at 37°C, the absorbance of the hydroxylated salicylate complex was measured at 562 nm.^([@B17])^

Experimental design
-------------------

### Animals and experimental protocol.

Swiss male albino mice (20--25 g) were used for the acute study LD50 of methanolic extract of the plant under investigation was determined according to Behrens and Karber.^([@B18])^

### Acute toxicity study.

It was found that the tested extracts were not mortal even at a dose of 3,000 mg/kg and consequently the dose 300 mg/kg was selected for the study.

Thirty six male Wister albino rats weighing (150--200) g were used for this study. The animals were housed in a temperature (25 ± 1°C), humidity controlled room and a 12 h light-dark cycle (lights on at 6:00). Rats were allowed free access to tap water and standard pellet diet. The institutional Animal Ethics Committee approved all experimental protocols. The animals were classified into 6 groups, each of 6 as follows:

- Control group (C): Rats received distilled water.

- GM: Rats received subcutaneous injection of GM (80 mg/kg body weight/day) for 6 consecutive days.

Curative groups:

- GM and *Casuarina equisetifolia* extract treated group, (GM + E): Rats received subcutaneous injection of GM (80 mg/kg body weight/day) for 6 consecutive days, followed by oral administration of *Casuarina equisetifolia* extract a dose of 300 mg/kg once daily for 4 weeks.

- GM and Silymarin (Reference drug) treated group, (GM + R): Rats received subcutaneous injection of GM (80 mg/kg body weight/day) for 6 consecutive days, followed by oral administration of Silymarin a dose of 50 mg/kg once daily for 4 weeks.

Protective groups:

- *Casuarina equisetifolia* extract and GM treated group (E + GM): Rats received oral administration of *Casuarina equisetifolia* extract at a dose of 300 mg/kg once daily for 4 weeks, followed by subcutaneous injection of GM (80 mg/kg body weight/day) for 6 consecutive days.

- Silymarin (Reference drug) and GM treated group (R + GM): Rats received oral administration of Silymarin at a dose of 50 mg/kg once daily for 4 weeks, followed by subcutaneous injection of GM (80 mg/kg body weight/day) for six consecutive days.

Blood collection and biochemical assays
---------------------------------------

Fasting blood samples were withdrawn from the retro-orbital vein of each animal using a glass capillary tube after fasting period of 12 h. The blood samples allowed to coagulate and then centrifuged at 3,000 rpm for 20 min. The separated sera were used for the estimation of serum activities of alanine transaminase (ALT), aspartate transaminase (AST) by using commercial kits (Quimica Clinica Aplicada, Spain). Serum urea and creatinine level was determined using commercial kits purchased from Stanbio, Boerne, TX. Serum potassium and uric acids concentrations were evaluated using kits from Biodiagnostic, Egypt. Serum vitamin C level was assayed using the method described by Jagota and Dani.^([@B19])^

Preparation of renal homogenate
-------------------------------

The whole kidney was accurately weighed and homogenized in ice-saline to prepare a 10% (w/v) tissue homogenate. The homogenate was used for the determination of malondialdehyde level (MDA) and reduced glutathione level (GSH), superoxide dismutase activity (SOD), glutathione-S-transferase activity (GST) and nitric oxide level (NO).

Determination of protein content
--------------------------------

The protein content of kidney homogenates was evaluated by following the method of Lowry *et al.*^([@B20])^ and using bovine serum albumin as a standard.

Biochemical analysis in kidney homogenate
-----------------------------------------

### Determination of lipid peroxidation.

MDA, as lipid peroxidation end product within kidney tissues, was quantified via the established measurement of the level of thiobarbituric acid reactive substances (TBARS). An aliquot of 0.5 ml of 10% homogenate (or standard) was pipetted into a 10 ml centrifuge tube followed by the addition of 3 ml of 1% orthophophoric acid and 1 ml of 0.6% thiobarbituric acid. After heating for 45 min in a boiling water bath, the mixture was then cooled and 4 ml of n-butanol was added and mixed vigorously. The upper butanol layer was separated by centrifugation and absorbance was measured at 535 nm and 520 nm against a reagent blank.^([@B21])^

### Determination of GSH level.

GSH level in renal tissue homogenates was measured by the method of Ellman.^([@B22])^ Trichloroacetic acid (5%) was added to adequate dilution of tissue homogenates (0.5 ml) to precipitate the protein content in the samples. Then, this mixture was centrifuged at 10,000 g, 5 min and the supernatant was recovered. Finally, 5,5\'-dithiobis(2-nitrobenzoic acid) solution was added to the reaction mixtures, and the absorbance was recorded at 412 nm using spectrophotometer.

### Determination of SOD activity.

SOD activity in renal tissues was determined by the method of Marklund and Marklund.^([@B23])^ Pyrogallol (24 mM) was prepared in 10 mM HC1 and kept at 4°C before use. Stock catalase solution (30 µM) was prepared in phosphate buffer (PH 9, 0.1 M), 100 µl of the supernatant was added to Tris HC1 buffer (pH 7.8, 0.1 M) containing 25 µl pyrogallol and 10 µl catalase. The final volume was adjusted to 3 ml using the same buffer solution. Changes in the absorbance at 420 nm were recorded at 1 min. interval for 3 min. Data were expressed as U/mg protein.

### Determination of GST activity.

GST activity in renal tissues was assayed according to the method of Habig *et al.*^([@B24])^ In brief, 2.8 ml of 0.1 M phosphate buffer pH 6.5, glutathione 100 µl and 1-chloro 2,4-dinitrobenzene 100 µl was mixed. The reaction was started by the addition of 25 µl of 10% homogenate fraction. The change in absorbance was observed by continuous recording at 340 nm at 1 min intervals for 3 min, the data were expressed as nmol/min/mg protein.

### Determination of NO content.

NO level in renal tissue homogenates was determined according to the method of Green *et al.*^([@B25])^ The assay is based on the diazotization of sulfanilic acid with nitric oxide at acidic pH and subsequent coupling with *N*-(10-naphthyl)-ethylenediamine to yield an intensely pink colored product that is measured spectrophotometrically at 540 nm. Sodium nitrite was used as standard.

Statistical analysis
--------------------

Statistical analysis of differences between means was carried out using ANOVA, followed by the least significant difference (LSD) test for multiple comparisons using SPSS for Windows software, ver. 6.0 (Chicago, IL); *p*\<0.05 was considered statistically significant for all tests.

Results
=======

Phytochemical analysis of methanolic extract of *Casuarina equisetifolia* leaves revealed the presence of tannins, flavonoids, alkaloids, phenolics, terpenoids and steroids (Table [1](#T1){ref-type="table"}).

Identification of quantification of phenolic compounds
------------------------------------------------------

Fig. [1](#F1){ref-type="fig"} represents the separation of phenolic compounds of *Casuarina equisetifolia* leaves extract. HPLC analysis of the total phenolic contents of methanolic extract of the aerial parts of *Casuarina equisetifolia* revealed the presence of 9 phenolic compounds as gallic acid, protochatechuic acid, *para*-coumaric acid, chlorogenic acid, salicylic acid, benzoic acid, catechol, pyrogallol and chrysin in concentration of (21.41, 13.15, 0.73, 129.42, 3.14, 181.39, 16.17, 1,049.9 and 3.04 mg/100 g plant extract respectively). Pyrogallol represented the highest concentration of the identified phenolic compounds while *para*-coumaric acid was the lowest concentration (Table [2](#T2){ref-type="table"}).

Identification of quantification of flavonoids
----------------------------------------------

Fig. [2](#F2){ref-type="fig"} represents the separation of flavonoids and flavonols of *Casuarina equisetifolia* leaves extract. HPLC analysis of the total flavonoidal contents of the same plant extract showed the presence of flavonol constituents as quercitin, rutin and kampferol, flavone constituents as hesperitin and apigenin and flavanone constituent as narenginin in the concentration of (837.9, 834.6, 399.2, 206.2, 59.9 and 384.8 mg/100 g plant extract respectively). Quercitin represented the highest concentration flavonoidal compound while apigenin was the lowest concentration, (Table [3](#T3){ref-type="table"}).

The content of flavonoidal compounds (mg %)
-------------------------------------------

The flavonoidal content was found to be 11.66 ± 0.2 mg % rutin equivalent.

DPPH^•^ radical scavenging activity
-----------------------------------

*Casuarina equisetifolia* extract scavenges DPPH radicals in a dose dependent manner (10--100) µg, with a 50% inhibition (IC50) at a concentration of 18 µg (Fig. [3](#F3){ref-type="fig"}).

NO radical inhibition
---------------------

The scavenging of NO by extract was increased in a dose dependent manner as illustrated in Fig. [4](#F4){ref-type="fig"}. At concentration of 800 µg of extract 50% of NO generated by incubation was scavenged.

Hydroxyl radical (^•^OH) scavenging activity
--------------------------------------------

The extract of *Casuarina equisetifolia* exhibited a significant dose dependent inhibition of ^•^OH activity, with a 50% inhibition (IC50) at a concentration of 4 µg (Fig. [5](#F5){ref-type="fig"}).

Reducing power
--------------

The reducing power of extract of *Casuarina equisetifolia* was very potent and the reducing power of the extract was increased with concentration of sample. The plant extract could reduce the most Fe^3+^ ions (Fig. [6](#F6){ref-type="fig"}).

Effect of *Casuarina equisetifolia* extract on GM-induced renal dysfunction
---------------------------------------------------------------------------

Subcutaneous injection of normal rats with GM caused a significant increase in serum urea, creatinine, uric acid levels and a significant reduction in serum potassium concentration with respect to normal controls, *p*\<0.05. Whereas in both protective and curative groups the oral administration of *Casuarina equisetifolia* extract as well as Silymarin (reference drug) to GM-intoxicated rats significantly normalized renal dysfunction, the effect was prominent in the protective groups (Table [4](#T4){ref-type="table"}). The treatment of rats with *Casuarina equisetifolia* extract showed normal serum ALT and serum AST activities indicating its safety.

Effect of *Casuarina equisetifolia* extract and/or GM treatment on GST, SOD activities and GSH level in renal homogenate
------------------------------------------------------------------------------------------------------------------------

GM intoxication caused a significant decrease in renal GST, SOD activities and GSH level as compared with normal controls, *p*\<0.05. Either treatment with *Casuarina equisetifolia* extract as well as Silymarin before GM (protective group, E + GM) or after GM (curative group, GM + E) revealed a significant increase in GST, SOD activities and GSH level as compared to GM intoxicated rats, *p*\<0.05, (Table [5](#T5){ref-type="table"}).

Effect of *Casuarina equisetifolia* extract and/or GM treatment on MDA and NO level in renal homogenate
-------------------------------------------------------------------------------------------------------

GM intoxication caused a significant increase in MDA and NO level as compared with normal controls, *p*\<0.05. Either treatment with *Casuarina equisetifolia* extract as well as Silymarin revealed a significant decrease in MDA and NO levels as compared to GM intoxicated one (*p*\<0.05, Table [5](#T5){ref-type="table"}).

Discussion
==========

The present study demonstrated protective and curative effects of *Casuarina equisetifolia* leaves extract, on GM-induced nephrotoxicity, in line with the consideration that oxygen-free radicals are important mediators of GM-induced acute renal failure.

In the present study, GM administration caused marked renal dysfunction as evidenced by the significant increase in serum urea, creatinine and uric acid levels along with a significant depletion in serum K^+^ level. It is well documented that GM nephrotoxicity in experimental animals causes acute renal failure and reduction in serum K^+^ levels.^([@B26],[@B27])^

Recent evidence indicated that ROS are the potential mediators involved in GM-induced renal dysfunction. GM has been shown to enhance generation of superoxide anion (O~2~^•−^), peroxynitrite anion (ONOO^−^), hydrogen peroxide (H~2~O~2~), and (^•^OH) production from renal cortical mitochondria. The interaction between O~2~^•−^ and H~2~O~2~ in the presence of a metal catalyst (iron) leads to the generation of toxic ^•^OH, which induces peroxidation of the polyenoic lipids of the endoplasmic reticulum and subsequent generation of secondary free radicals derived from these lipids. This destructive lipid peroxidation leads to breakdown of membrane structure and function. Further decomposition of peroxidized lipids yields a wide variety of end products, including MDA.^([@B28])^ This GM-induced oxidative stress is the central pathway responsible for nephrotoxicity.^([@B29],[@B30])^

In our work, oral administration of *Casuarina equisetifolia* leaves extract to GM-intoxicated rats normalized serum urea, Creatinine, uric acid and K^+^ levels, suggesting that the extract under investigation may introduce protection against GM-induced nephrotoxicity, possibly by attenuating the oxidative stress induced by administration of GM.

GSH depletion is a common consequence of increased formation of ROS. An explanation to cellular GSH depletion after GM intoxication is the increased consumption of GSH in non-enzymatic removal of oxygen radicals, or the oxidation of sulfhydryl group existing at the active site of the enzyme molecule.^([@B31])^

Also, it has been reported that depletion of cellular GSH level results in a concomitant decrease in glutathione-related enzymes activity.^([@B32])^ Oxidative stress in renal tissue leads to diminished SOD activity.^([@B33])^

Most of the antioxidant enzymes become inactive in response to oxidative stress.^([@B34])^ The decrease of SOD and GST activities in the kidney tissues by GM administration in the present investigation run in parallel to the study of Pedraza-Chaverri *et al.*^([@B35])^ However, Free radicals are causative factors for aminoglycosides (GM) induced renal toxicity.^([@B36])^ It has demonstrated that GM generates ROS that mediate biomolecules oxidation in the kidney.^([@B37])^ The excessive ROS can damage the protein sensitive thiols. Therefore, GM inhibits the activities of antioxidant enzymes, GST and SOD and depletes thiol cellular content.^([@B38])^ In our work, *Casuarina equisetifolia* leaves extract consumption improves GSH content and SOD as well as GST activities. These results demonstrated that *Casuarina equisetifolia* leaves extract significantly enhanced antioxidant defense against GM induced oxidative damage in renal tissues. This may be attributed to free radical scavenging property of extract as well as direct antioxidant action.^([@B39])^

The findings in the current study is consistent with data of Alqasoumi *et al.*,^([@B40])^ the author investigated the possible protective effect of water spinach *Ipomea aquatica*ethanol extract against GM-induced nephrotoxicity in Wistar albino rats. The author found that concomitant administration of *Ipomea aquatica*extract attenuated the harmful effects of GM both by inhibiting free-radical formation and/or by restoration of the antioxidant systems. The author attributed the protective effect of *Ipomea aquatica* to the presence of flavonoids and tannins that are known to possess potent antioxidant and free radical scavenging properties.

In a previous study was conducted by Shirwaikar *et al.*,^([@B41])^ the author studied the protective activity of ethanolic extract of *Aerva lanata* in cisplatin and GM-induced nephrotoxicity in male Wistar albino rats. The author found that the ethanol extract of *Aerva lanata* was found to normalize the raised blood urea, serum creatinine and bring about marked recovery in kidneys. The author mentioned that flavonoids such as kaempferol 3-rhamnoside and kaempferol 3-rhamnogalactoside have been reported to be present in *Aerva lanata*. Flavonoids are well known potent antioxidant and free radical scavengers. Hence, the probable mechanism of nephroprotection by *Aerva* *lanata*may be attributed to its antioxidant and free radical scavenging property.

Natural antioxidants such as flavonoids and polyphenols are believed to possess antioxidant properties due to their reducing and chelating capabilities. Flavonoids and polyphenols are secondary plant metabolites that are widely distributed in fruits, leaves, bark, and other parts in plants with free radical scavenging abilities.^([@B42])^

In the present study, there was a significant increase in renal NO in GM-treated rats. The rise of renal NO in GM-treated rats has been previously reported.^([@B43])^ This supported by the finding of Abdelaziz and Kandeel.^([@B44])^ The authors demonstrated that NO was increased by GM induced renal toxicity.

Moreover, Kandeel *et al*.^([@B45])^ reported that there are an increase in the levels of oxidative stress biomarkers including NO in response to GM toxicity. NO induce renal cellular damage through formation of peroxynitrite that provoke the damage to the cellular structural molecules. However, Abdelaziz and Kandeel^([@B44])^ demonstrated that the renal toxic effect of GM mediated by increase of NO is ameliorated by antioxidants. In the present study, the normalization in the level of renal NO could be attributed to antioxidant activity of the *Casuarina equisetifolia* extract.

Preliminary phytochemical screening of *Casuarina equisetifolia* extract revealed the presence of alkaloids, terpenoids, flavonoids, polyphenols, steroids and tannins. Tannins are complex polyphenolic compounds widely found in higher plants. Similar to many polyphenols, tannin has been shown to possess antioxidant activity.^([@B46],[@B47])^

The antioxidant activity of *Casuarina equisetifolia* extract could be also attributed to its flavonoidal content. Flavonoids act as scavengers of various oxidizing species i.e., O~2~^•−^, ^•^OH or peroxyl radicals, they also act as quenchers of singlet oxygen.^([@B48])^ Numerous plant constituents have proven to show free radical scavenging or antioxidants activity.^([@B49])^ Phenols are very important plant constituents. There is a highly positive relationship between total phenols and antioxidant activity of many plant species, because of the scavenging ability of their hydroxyl groups. It was also reported that phenolic compounds are effective hydrogen donors, making them very good antioxidants.^([@B50])^

The potential pathological role of oxidative and nitrosative stress in renal damage was reported previously.^([@B51])^ The direct contribution of ^•^OH in the pathogenesis of nephrotoxicity are also well substantiated.^([@B52])^ The nephroprotective effect of *Casuarina equisetifolia* extract may therefore be attributed to its potent nitric oxide and ^•^OH scavenging effects.^([@B53],[@B54])^

In conclusion, it is proposed that the nephroprotective activities of the *Casuarina equisetifolia* leaves extract in GM-induced nephrotoxicity may be due to presence of phytochemicals like flavonoids, tannins which may act as antioxidants individually or synergistically. *Casuarina equisetifolia* leaves extract could constitute a lead to discovering a novel pharmaceutical formulation which will be useful for treatment of drug-induced nephrotoxicity.
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###### 

Phytochemical analysis of methanolic extract of *Casuarina* *equisetifolia* leaves

  Chemical group   Identification
  ---------------- ----------------
  Tannins          ++++
  Flavonoids       +++
  Saponins         \-
  Alkaloids        \+
  Phenolics        ++++
  Terpenoids       \+
  Steroids         \+

###### 

Identified phenolics in methanolic extract of *Casuarina equisetifolia* leaves

  Test items       Concentration (mg/100 g)
  ---------------- --------------------------
  Gallic           21.41
  Protocatechuic   13.15
  P-Coumaric       0.73
  Chlorogenic      129.42
  Catechol         16.17
  Pyrogallol       1049.9
  Salicylic        3.14
  Chrysin          3.04
  Benzoic          181.39

###### 

Identified flavonoids in methanolic extract of *Casuarina equisetifolia* leaves

  Test items   Concentration (mg/100 g)
  ------------ --------------------------
  Rutin        834.6
  Rosmarinic   384.6
  Quercitin    837.9
  Hesperetin   206.2
  Narenginin   384.8
  Apignen      59.9
  Kampferol    399.2

###### 

Effect of *Casuarina equisetifolia* extract and/or GM treatment on studied serum biochemical parameters

  Group    Urea (mg/dl)          Creatinine (mg/dl)   Uric acid (mg/dl)   Potassium (mmol/L)     Vitamin C (mg/dl)   SALT (U/L)   SAST (U/L)
  -------- --------------------- -------------------- ------------------- ---------------------- ------------------- ------------ -------------
  C        23.43 ± 1.2           0.43 ± 0.014         1.47 ± 0.094        5.29 ± 0.4             1.39 ± 0.15         26.6 ± 2     52.1 ± 4.9
  GM       119 ± 10.2\*          1.97 ± 0.063\*       2.53 ± 0.16\*       4.07 ± 0.03\*          0.82 ± 0.02\*       27.8 ± 2.2   54.4 ± 3.9
  GM + E   33 ± 2\*^†‡^\*\*      0.43 ± 0.01\*\*      1.21 ± 0.11\*\*     5.86 ± 0.26\*\*        1.49 ± 0.12\*\*     29 ± 1.9     53 ± 5
  E + GM   23.88 ± 1\*\*         0.44 ± 0.02\*\*      0.92 ± 0.1\* \*\*   4.83 ± 0.04\*\*^§^     1.56 ± 0.099\*\*    28.2 ± 2.5   52 ± 5.1
  GM + R   29.4 ± 2.3\*^†^\*\*   0.39 ± 0.01\*\*      1.0 ± 0.03\* \*\*   4.9 ± 0.15\*\*^§^      1.34 ± 0.12\*\*     29.3 ± 2.4   55.6 ± 4.89
  R + GM   27.31 ± 1.5\*\*       0.41 ± 0.007\*\*     1.1 ± 0.04\* \*\*   4.55 ± 0.02\*^§^\*\*   1.48 ± 0.04\*\*     28.4 ± 2.3   51 ± 3.78

Results are expressed as mean ± SE. \*Significantly different from control group, \*\*Significantly different from GM treated group, ^†^Groups GM + E and GM + R are significantly different from group E + GM, ^‡^Group R + GM is significantly different from group GM + E, ^§^Groups E + GM, GM + R and R + GM are significantly different from group GM + E.

###### 

Effect of *Casuarina equisetifolia* extract and/or GM treatment on GST, SOD activities, GSH, MDA and NO level in renal homogenate

  Group    GST (nmol/min/mg protein)   SOD (U/mg protein)   GSH (nmol/mg protein)   MDA (nmol/g tissue)   NO (µmol/g wt tissue)
  -------- --------------------------- -------------------- ----------------------- --------------------- -----------------------
  C        45.6 ± 1.9                  55.2 ± 1.27          20 ± 0.78               52.6 ± 1.04           125 ± 3.95
  GM       38.8 ± 1\*                  46.2 ± 1.4\*         15.9 ± 0.45\*           60.4 ± 0.6\*          140 ± 1.38\*
  GM + E   43.8 ± 064\*\*              53.1 ± 1.1\*\*^§^    19.4 ± 0.49\*\*         54 ± 0.75\*\*         123 ± 2.75\*\*
  E + GM   44.3 ± 0.89\*\*             52.4 ± 0.76\*\*^§^   19.2 ± 0.5\*\*          54.6 ± 0.7\*\*        126 ± 2.39\*\*
  GM + R   48.8 ± 0.6\*\*^†‡^          59 ± 1.86\*\*        19.9 ± 0.86\*\*         52.4 ± 0.8\*\*        125 ± 3.2\*\*
  R + GM   47.2 ± 1\*\*^†^             58.8 ± 1.8\*\*       21 ± 0.8\*\*            53.4 ± 0.7\*\*        126 ± 3.5\*\*

Results are expressed as mean ± SE. \*Significantly different from control group, \*\*Significantly different from (GM) treated group, ^†^Groups GM + R and R + GM are significantly different from group GM + E, ^‡^Group GM + R is significantly different from group E + GM, ^§^Groups GM + E and E + GM are significantly different from groups GM + R and R + GM.
